Inventor
FRAZEE JAMES S
US15 patents
⚠️ This page may combine multiple inventors who share the name “FRAZEE JAMES S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
8 patentsUS6037367AMar 14, 2000
Substituted-pent-4-ynoic acids
SMITHKLINE BEECHAM CORP73 citations95
US7365085B2Apr 29, 2008
Compounds and methods
SMITHKLINE BEECHAM CORP25 citations90
US5314918AMay 24, 1994
Leukotriene antagonists
SMITHKLINE BEECHAM CORP7 citations73
US4996214AFeb 26, 1991
Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids and leucotriene antagonist use thereof
SMITHKLINE BEECHAM CORP7 citations70
US4992459AFeb 12, 1991
Dopamine-β-hydroxylase inhibitors
SMITHKLINE BEECHAM CORP4 citations61
US7323494B2Jan 29, 2008
Compounds and methods
SMITHKLINE BEECHAM CORP4 citations60
US5034537AJul 23, 1991
Leukotriene antagonists
SMITHKLINE BEECHAM CORP1 citations51
US6967220B2Nov 22, 2005
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP0 citations38
SMITHKLINE BECKMAN CORP
5 patentsUS4760089AJul 26, 1988
Irreversible dopamine-β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP27 citations91
US4532331AJul 30, 1985
1-Benzyl-2-aminomethyl imidazole derivatives
SMITHKLINE BECKMAN CORP23 citations82
US4772723ASep 20, 1988
Dopamine β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP3 citations62
US4743613AMay 10, 1988
Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
SMITHKLINE BECKMAN CORP3 citations62
US4863944ASep 5, 1989
Dopamine-β-hydroxylase inhibitors
SMITHKLINE BECKMAN CORP1 citations51